Obstructed site | Number | Age | Sex (male/ female) | Intubation perriod (day) | Obseravation period (month) | TMH (μm) | P value | |
---|---|---|---|---|---|---|---|---|
Pre | Post | |||||||
All patients | 91 | 69.7 ± 10.4 | 23/68 | 97.8 ± 58.2 | 15.7 ± 12.4 | 0.429 ± 0.274 | 0.235 ± 0.151 | p < 0.0001 |
Lacrimal punctum | 5 | 54.0 ± 19.6 | 0/5 | 68.2 ± 19.9 | 6.0 ± 0.0 | 0.406 ± 0.154 | 0.311 ± 0.168 | p = 0.3258 |
Lacrimal canaliculus | 27 | 69.3 ± 9.8 | 8/19 | 91.0 ± 45.8 | 15.6 ± 10.3 | 0.497 ± 0.272 | 0.265 ± 0.206 | p < 0.0001 |
Common lacrimal canaliculus and nasolacrimal duct | 3 | 70.0 ± 10.0 | 0/3 | 199.7 ± 196.9 | 14.3 ± 8.5 | 0.403 ± 0.211 | 0.175 ± 0.092 | p = 0.0944 |
Lacrimal sac | 17 | 71.2 ± 7.9 | 4/13 | 86.9 ± 28.3 | 20.0 ± 16.6 | 0.468 ± 0.401 | 0.210 ± 0.122 | p = 0.0028 |
Proximal nasolacrimal duct | 23 | 72.1 ± 9.2 | 5/18 | 88.0 ± 10.7 | 16.6 ± 13.9 | 0.351 ± 0.226 | 0.212 ± 0.109 | p = 0.0014 |
Distal nasolacrimal duct | 16 | 70.1 ± 9.1 | 6/10 | 102.2 ± 37.8 | 11.0 ± 7.3 | 0.393 ± 0.202 | 0.229 ± 0.117 | p = 0.0055 |
Group 1 | 35 | 67.2 ± 12.4 | 8/27 | 106.5 ± 88.0 | 14.8 ± 10.0 | 0.476 ± 0.252 | 0.264 ± 0.193 | p < 0.0001 |
Group 2 | 56 | 71.3 ± 8.7 | 15/41 | 92.7 ± 30.5 | 16.2 ± 13.7 | 0.399 ± 0.285 | 0.216 ± 0.114 | p < 0.0001 |